C. Telford

发表

The use of multiple sclerosis condition-specific measures to inform health policy decision-making: mapping from the MSWS-12 to the EQ-5D

J. Zajicek, C. Green, A. Hawton, 2012, Multiple sclerosis.

Network Meta-Analysis Comparing Overall Survival for Fulvestrant 500 mg Versus Alternative Therapies for Treatment of Postmenopausal, Estrogen Receptor-Positive Advanced Breast Cancer Following Failure on Prior Endocrine Therapy.

C. Telford, N. Jones, C. Livings, 2016, Clinical breast cancer.

Economic Evaluation of Fulvestrant 500 mg Compared to Generic Aromatase Inhibitors in Patients with Advanced Breast Cancer in Sweden

M. Ekman, C. Telford, C. Livings, 2017, PharmacoEconomics - Open.

BRCA testing and outcomes in women with breast cancer

R. Deka, D. Brixner, H. Bauer, 2021, Breast Cancer Research and Treatment.

Matching-adjusted Indirect Comparisons of the Efficacy and Safety of Acalabrutinib Versus Other Targeted Therapies in Relapsed/Refractory Mantle Cell Lymphoma.

Jinlin Song, J. Zhao, C. Telford, 2019, Clinical therapeutics.

Clinical outcomes of female breast cancer according to BRCA mutation status.

H. Sørensen, M. Nørgaard, M. Thomassen, 2017, Cancer epidemiology.

Exploring socioeconomic disparities in self-reported oral health among adolescents in california.

L. Murray, C. Telford, I. Coulter, 2011, Journal of the American Dental Association.

Estimating the costs of ongoing care for adolescents with attention-deficit hyperactivity disorder

A. Thapar, K. Langley, S. Logan, 2013, Social Psychiatry and Psychiatric Epidemiology.

An analysis examining socio-economic variations in the provision of NHS general dental practitioner care under a fee for service contract among adolescents: Northern Ireland Longitudinal Study.

L. Murray, C. Telford, C. O’Neill, 2012, Community dentistry and oral epidemiology.

The i-gel Supraglottic Airway as a Conduit for Fibreoptic Tracheal Intubation - A Randomized Comparison with the Single-use Intubating Laryngeal Mask Airway and CTrach Laryngeal Mask in Patients with Predicted Difficult Laryngoscopy.

C. Telford, W. Donaldson, F. McAleavey, 2016, Prague medical report.

Matching-adjusted indirect comparisons of safety and efficacy of acalabrutinib versus other targeted therapies in patients with treatment-naïve chronic lymphocytic leukemia

M. Davids, I. Ringshausen, C. Telford, 2021, Leukemia & lymphoma.

Cost-Effectiveness Analysis of Fulvestrant 500 mg in Endocrine Therapy-Naïve Postmenopausal Women with Hormone Receptor-Positive Advanced Breast Cancer in the UK

M. Ekman, C. Telford, E. Bertranou, 2019, PharmacoEconomics - open.

RE: "Cost-effectiveness analysis of fulvestrant versus anastrozole as first-line treatment for hormone receptor-positive advanced breast cancer," by Ding H., et al.

C. Telford, 2018, European journal of cancer care.

Changes in dental health investment across the adolescent years

C. Telford, C. O’Neill, C. O’Neill, 2012, BDJ.

Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.

J. Zajicek, C. Green, A. Hawton, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Survival Outcomes in BRCA1 or BRCA2 Mutation Carriers and the Influence of Triple-Negative Breast Cancer Subtype

J. Tyczynski, C. Telford, R. Haque, 2018 .

Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D.

J. Zajicek, C. Green, A. Hawton, 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

Clinical outcomes of female breast cancer according to BRCA mutation status.

H. Sørensen, M. Nørgaard, M. Thomassen, 2017, Cancer epidemiology.